» Articles » PMID: 37053191

Mapping CircRNA-miRNA-mRNA Regulatory Axis Identifies Hsa_circ_0080942 and Hsa_circ_0080135 As a Potential Theranostic Agents for SARS-CoV-2 Infection

Overview
Journal PLoS One
Date 2023 Apr 13
PMID 37053191
Authors
Affiliations
Soon will be listed here.
Abstract

Non-coding RNAs (ncRNAs) can control the flux of genetic information; affect RNA stability and play crucial roles in mediating epigenetic modifications. A number of studies have highlighted the potential roles of both virus-encoded and host-encoded ncRNAs in viral infections, transmission and therapeutics. However, the role of an emerging type of non-coding transcript, circular RNA (circRNA) in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has not been fully elucidated so far. Moreover, the potential pathogenic role of circRNA-miRNA-mRNA regulatory axis has not been fully explored as yet. The current study aimed to holistically map the regulatory networks driven by SARS-CoV-2 related circRNAs, miRNAs and mRNAs to uncover plausible interactions and interplay amongst them in order to explore possible therapeutic options in SARS-CoV-2 infection. Patient datasets were analyzed systematically in a unified approach to explore circRNA, miRNA, and mRNA expression profiles. CircRNA-miRNA-mRNA network was constructed based on cytokine storm related circRNAs forming a total of 165 circRNA-miRNA-mRNA pairs. This study implies the potential regulatory role of the obtained circRNA-miRNA-mRNA network and proposes that two differentially expressed circRNAs hsa_circ_0080942 and hsa_circ_0080135 might serve as a potential theranostic agents for SARS-CoV-2 infection. Collectively, the results shed light on the functional role of circRNAs as ceRNAs to sponge miRNA and regulate mRNA expression during SARS-CoV-2 infection.

Citing Articles

Circular RNAs in the pathogenesis of SARS-CoV-2: potential diagnostic biomarkers and therapeutic targets.

Wu J, Li L, Xu W, Xia X, Wu Y Funct Integr Genomics. 2025; 25(1):4.

PMID: 39745517 DOI: 10.1007/s10142-024-01509-6.


Ferroptosis and circular RNAs: new horizons in cancer therapy.

Bhat A, Kukreti N, Afzal M, Goyal A, Thapa R, Ali H EXCLI J. 2024; 23:570-599.

PMID: 38887390 PMC: 11180955. DOI: 10.17179/excli2024-7005.


CircRNA: a rising therapeutic strategy for lung injury induced by pulmonary toxicants.

Liao C, He Z, Yu R, Yu Y, Liu X, Kong D Arch Toxicol. 2024; 98(5):1297-1310.

PMID: 38498160 DOI: 10.1007/s00204-024-03706-5.


Non-coding RNAs expression in SARS-CoV-2 infection: pathogenesis, clinical significance, and therapeutic targets.

Liu X, Xiong W, Ye M, Lu T, Yuan K, Chang S Signal Transduct Target Ther. 2023; 8(1):441.

PMID: 38057315 PMC: 10700414. DOI: 10.1038/s41392-023-01669-0.


Computational identification of differentially-expressed genes as suggested novel COVID-19 biomarkers: A bioinformatics analysis of expression profiles.

Di Salvatore V, Crispino E, Maleki A, Nicotra G, Russo G, Pappalardo F Comput Struct Biotechnol J. 2023; 21:3339-3354.

PMID: 37347079 PMC: 10259169. DOI: 10.1016/j.csbj.2023.06.007.

References
1.
Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y . Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020; 71(15):762-768. PMC: 7108125. DOI: 10.1093/cid/ciaa248. View

2.
Girardi E, Lopez P, Pfeffer S . On the Importance of Host MicroRNAs During Viral Infection. Front Genet. 2018; 9:439. PMC: 6176045. DOI: 10.3389/fgene.2018.00439. View

3.
Chen L, Liu H, Liu W, Liu J, Liu K, Shang J . [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi. 2020; 43(0):E005. DOI: 10.3760/cma.j.issn.1001-0939.2020.0005. View

4.
Rong D, Sun H, Li Z, Liu S, Dong C, Fu K . An emerging function of circRNA-miRNAs-mRNA axis in human diseases. Oncotarget. 2017; 8(42):73271-73281. PMC: 5641211. DOI: 10.18632/oncotarget.19154. View

5.
Kang J, Tang Q, He J, Li L, Yang N, Yu S . RNAInter v4.0: RNA interactome repository with redefined confidence scoring system and improved accessibility. Nucleic Acids Res. 2021; 50(D1):D326-D332. PMC: 8728132. DOI: 10.1093/nar/gkab997. View